Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy
- PMID: 1775249
- DOI: 10.1093/ndt/6.11.846
Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy
Abstract
A predominant expression of IgA1 in mesangial deposits, serum, and bone marrow culture supernatants has been shown in IgA nephropathy (IgAN). Furthermore an excess of lambda light chains in both mesangial deposits and serum IgA has been observed. However, the origin of mesangial IgA remains controversial. In the present study, we have examined the IgA1 light chain type in IgAN. Total IgA1, IgA1 kappa and IgA1 lambda were measured by ELISA in serum and culture supernatants from spontaneous and pokeweed-mitogen (PWM)-stimulated peripheral blood mononuclear cells (PBMC). We observed an increase in IgA and IgA1 serum concentrations in IgA nephropathy patients, with a ratio of serum IgA1 to total serum IgA identical between patients and controls. The concentration of serum IgA kappa did not differ between patients and controls but patients had a significantly higher concentration of serum IgA lambda. The IgA1 kappa to IgA1 lambda ratio was 1.06 +/- 0.42 in IgAN patients versus 1.55 +/- 0.36 in controls (P less than 0.01). By contrast, the concentrations of IgA1 kappa and IgA1 lambda in PBMC culture supernatants, both spontaneous and PWM-stimulated, were identical in patients and controls. Therefore, there is a specific increase in IgA1 lambda in patients' sera. This contrasts with the normal IgA1 production by PBMC, which are derived from mucosal-associated lymphoid tissues. This suggests that IgA isotypic deregulation is confined to the bone marrow compartment and is not a generalised defect of the IgA system.
Similar articles
-
Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay.Scand J Urol Nephrol. 1997 Jun;31(3):289-93. doi: 10.3109/00365599709070350. Scand J Urol Nephrol. 1997. PMID: 9249895
-
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.J Am Soc Nephrol. 2022 May;33(5):908-917. doi: 10.1681/ASN.2021081086. Epub 2022 Feb 3. J Am Soc Nephrol. 2022. PMID: 35115327 Free PMC article.
-
Light-chain ratio of serum IgA1 in IgA nephropathy.J Clin Immunol. 1991 Jul;11(4):219-23. doi: 10.1007/BF00917428. J Clin Immunol. 1991. PMID: 1918269
-
Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.Contrib Nephrol. 2007;157:144-7. doi: 10.1159/000102457. Contrib Nephrol. 2007. PMID: 17495453 Review.
-
Structural features of IgA molecules which contribute to IgA nephropathy.J Nephrol. 1999 Mar-Apr;12(2):59-65. J Nephrol. 1999. PMID: 10378660 Review.
Cited by
-
Pathogenesis of idiopathic IgA nephropathy.Pediatr Nephrol. 1993 Jun;7(3):303-11. doi: 10.1007/BF00853230. Pediatr Nephrol. 1993. PMID: 8518104 Review.
-
Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores.J Clin Med. 2023 Nov 28;12(23):7361. doi: 10.3390/jcm12237361. J Clin Med. 2023. PMID: 38068413 Free PMC article.
-
IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease.Front Immunol. 2023 Feb 7;14:1085922. doi: 10.3389/fimmu.2023.1085922. eCollection 2023. Front Immunol. 2023. PMID: 36865536 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous